These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8903486)

  • 1. UK Cancer Registry statistics--can the partially sighted lead the blind?
    Skidmore FD
    Eur J Surg Oncol; 1996 Oct; 22(5):467-8. PubMed ID: 8903486
    [No Abstract]   [Full Text] [Related]  

  • 2. The reliability of cancer registry records.
    Gulliford M
    Qual Health Care; 1996 Jun; 5(2):120-1. PubMed ID: 10158590
    [No Abstract]   [Full Text] [Related]  

  • 3. Value of head and neck cancer incidence data on UK cancer registry websites: a comparison.
    Khan AM; Tomkinson A
    J Laryngol Otol; 2007 Nov; 121(11):1079-82. PubMed ID: 17319982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half of the UK population can expect a diagnosis of cancer.
    Torjesen I
    BMJ; 2015 Feb; 350():h614. PubMed ID: 25652074
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer registries: should informed consent be required?
    Illman J
    J Natl Cancer Inst; 2002 Sep; 94(17):1269-70. PubMed ID: 12208889
    [No Abstract]   [Full Text] [Related]  

  • 6. Data Resource Profile: The UK Cystic Fibrosis Registry.
    Taylor-Robinson D; Archangelidi O; Carr SB; Cosgriff R; Gunn E; Keogh RH; MacDougall A; Newsome S; Schlüter DK; Stanojevic S; Bilton D;
    Int J Epidemiol; 2018 Feb; 47(1):9-10e. PubMed ID: 29040601
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer registries fear imminent collapse.
    Brown P
    BMJ; 2000 Oct; 321(7265):849. PubMed ID: 11021848
    [No Abstract]   [Full Text] [Related]  

  • 8. The UK National Barrett's Oesophagus Registry: a study between two centres.
    Caygill CP; Reed PI; McIntyre A; Hill MJ
    Eur J Cancer Prev; 1998 Apr; 7(2):161-4. PubMed ID: 9818779
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of cancer registries.
    Pollock A
    BMJ; 1994 Oct; 309(6958):821-2. PubMed ID: 7950596
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer incidence in The Health Improvement Network.
    Haynes K; Forde KA; Schinnar R; Wong P; Strom BL; Lewis JD
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):730-6. PubMed ID: 19479713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National and international variation in the registration of bladder cancer.
    Crow P; Ritchie AW
    BJU Int; 2003 Oct; 92(6):563-6. PubMed ID: 14511034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of the understanding and application of UK blind registration criteria.
    Buchan JC; Cassels-Brown A
    Eur J Ophthalmol; 2008; 18(6):1037-8; author reply 1038. PubMed ID: 18988187
    [No Abstract]   [Full Text] [Related]  

  • 13. Registration of blind and partially sighted people.
    Wormald R; Evans J
    Br J Ophthalmol; 1994 Oct; 78(10):733-4. PubMed ID: 7803345
    [No Abstract]   [Full Text] [Related]  

  • 14. Making cancer statistics more informative: measures of the quality of recorded diagnosis in a population-based registry.
    Silcocks PB; Thornton-Jones H; Skeet RG
    Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1467-73. PubMed ID: 2591439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy registries: differences, similarities, and possible harmonization.
    Tomson T; Battino D; Craig J; Hernandez-Diaz S; Holmes LB; Lindhout D; Morrow J; French J;
    Epilepsia; 2010 May; 51(5):909-15. PubMed ID: 20196792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worldwide burden of cancer incidence in 2002 extrapolated from cancer incidence in five continents Vol. IX.
    Matsuda T; Saika K
    Jpn J Clin Oncol; 2012 Nov; 42(11):1111-2. PubMed ID: 23100612
    [No Abstract]   [Full Text] [Related]  

  • 17. The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017.
    Shillitoe B; Bangs C; Guzman D; Gennery AR; Longhurst HJ; Slatter M; Edgar DM; Thomas M; Worth A; Huissoon A; Arkwright PD; Jolles S; Bourne H; Alachkar H; Savic S; Kumararatne DS; Patel S; Baxendale H; Noorani S; Yong PFK; Waruiru C; Pavaladurai V; Kelleher P; Herriot R; Bernatonienne J; Bhole M; Steele C; Hayman G; Richter A; Gompels M; Chopra C; Garcez T; Buckland M
    Clin Exp Immunol; 2018 Jun; 192(3):284-291. PubMed ID: 29878323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of the standard mortality/incidence ratio in evaluation of completeness of population-based cancer registry data.
    Suwanrungruang K; Sriplung H; Temiyasathit S; Waisri N; Daoprasert K; Kamsa-Ard S; Tasanapitak C; McNeil E
    Asian Pac J Cancer Prev; 2011; 12(12):3283-8. PubMed ID: 22471467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing clinical data: a cancer registries update.
    Watkins S
    J AHIMA; 1997; 68(7):22-5. PubMed ID: 10168978
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients' denial of disease may pose difficulty for achieving informed consent.
    Gavin AT; Fitzpatrick D; Middleton RJ; Coleman MP
    BMJ; 2002 Apr; 324(7343):974. PubMed ID: 11964347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.